ArticleAnnals of the American Thoracic Society2024
Cardiopulmonary Exercise Testing Provides Prognostic Information in Advanced Cystic Fibrosis Lung Disease.
Open access · hybridAbstract read
In one paragraph
Article in Annals of the American Thoracic Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 12 citations in OpenAlex.
- Trial
- Rethinking normality in cardiopulmonary exercise testing: why percentile-based thresholds deserve a greater role.ERJ open research · 2026Article
- Prioritising cardiopulmonary exercise testing for adults with cystic fibrosis: a service evaluation.BMC pulmonary medicine · 2026Article
- Feasibility and inter-reporter variability of submaximal outcomes derived from cardiopulmonary exercise testing in people with advanced cystic fibrosis lung disease.ERJ open research · 2025Article
- Cardiopulmonary Exercise Testing for Prognostication in Advanced Cystic Fibrosis Lung Disease and Beyond.Annals of the American Thoracic Society · 2024Article
Corrections and comments
- Commented on by
Authors and funding
39 authors at 20 institutions in 10 countries.
Thomas RadtkeDivision of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, and.ORCID 0000-0002-1723-1070
Don S UrquhartDepartment of Paediatric Respiratory and Sleep Medicine, Royal Hospital for Children and Young People, Edinburgh, United Kingdom.ORCID 0000-0002-9048-9692
Julia BraunDivision of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, and.
Peter J BarryManchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom.
Ian WallerManchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom.
Nicole PetchManchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom.
Meir Mei-ZahavPulmonary Institute, Schneider Children's Medical Center of Israel and Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.
Mordechai R KramerPulmonary Institute, Schneider Children's Medical Center of Israel and Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.
Thong Hua-HuyService de Physiologie-Explorations Fonctionnelles, Hôpital Cochin, AP-HP, Université Paris Descartes, Paris, France.ORCID 0000-0003-3212-0560
Anh Tuan Dinh-XuanService de Physiologie-Explorations Fonctionnelles, Hôpital Cochin, AP-HP, Université Paris Descartes, Paris, France.
J Alastair InnesScottish Adult Cystic Fibrosis Service, Western General Hospital, and.
Sara McArthurRespiratory Physiology Service, NHS Lothian, Edinburgh, United Kingdom.
Aleksandar SovticMother and Child Health Institute, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Bojana GojsinaMother and Child Health Institute, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Samuel VergesUniversity Grenoble Alpes, INSERM, CHU Grenoble Alpes, HP2 Laboratory, Grenoble, France.
Tanguy de MaatUniversity Grenoble Alpes, INSERM, CHU Grenoble Alpes, HP2 Laboratory, Grenoble, France.
Lisa MorrisonWest of Scotland Adult Cystic Fibrosis Unit, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Jamie WoodRehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, New York.ORCID 0000-0003-3172-0863
Samantha CrutePhysiotherapy Department, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
Craig A WilliamsChildren's Health and Exercise Research Centre, Department of Public Health and Sports Science, University of Exeter, Exeter, United Kingdom.
Owen W TomlinsonRoyal Devon University Healthcare NHS Trust, Exeter, Exeter, United Kingdom.
Ronen Bar-YosephPediatric Pulmonary Institute, Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel.
Alexandra HebestreitUniversity Children's Hospital Wuerzburg, University Hospital of Wuerzburg, Wuerzburg, Germany.
Bradley S QuonAdult Cystic Fibrosis Program and.
Eugenie KwongAdult Cystic Fibrosis Program and.
Zoe L SaynorSchool of Sport, Health, and Exercise Science, Faculty of Science and Health, University of Portsmouth, Portsmouth, United Kingdom.
Adam J CauserSchool of Sport, Health, and Exercise Science, Faculty of Science and Health, University of Portsmouth, Portsmouth, United Kingdom.
Anne L StephensonAdult Cystic Fibrosis Center, St. Michael's Hospital.
Jane E SchneidermanDivision of Respiratory Medicine, The Hospital for Sick Children.
Michelle ShawDivision of Translational Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
Tiffany DwyerDiscipline of Physiotherapy, Sydney School of Health Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Daniel StevensDivision of Kinesiology, School of Health and Human Performance, Dalhousie University, Halifax, Nova Scotia, Canada.
Natascha RemusCentre Intercommunal de Créteil, Service de Pneumologie, INSERM, U955, Université Paris-Est, Créteil, France; and.
Benoit DouvryCentre Intercommunal de Créteil, Service de Pneumologie, INSERM, U955, Université Paris-Est, Créteil, France; and.
Karla FosterPulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Christian BendenFaculty of Medicine, University of Zurich, Zurich, Switzerland.
Felix RatjenDivision of Respiratory Medicine, The Hospital for Sick Children.
Helge HebestreitUniversity Children's Hospital Wuerzburg, University Hospital of Wuerzburg, Wuerzburg, Germany.
Prognostic Value of CPET in CF Study Group
Inserm · FRManchester University NHS Foundation Trust · GBUniversity of Zurich · CHSir Charles Gairdner Hospital · AUTel Aviv University · ILUniversitätsklinikum Würzburg · DEUniversité Paris Cité · FRUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Belgrade · RSUniversity of Toronto · CACincinnati Children's Hospital Medical Center · USDalhousie University · CAHospital for Sick Children · CANHS Lothian · GBQueen Elizabeth University Hospital · GBRambam Health Care Campus · ILRoyal Devon & Exeter NHS Foundation Trust · GBRoyal Hospital for Children · GBSt. Michael's Hospital · CASt. Paul's Hospital · CA
Funding
Lunge Zürich 2019-06
Abstract
PubMed holds no abstract for this paper.
Indexed as
Cystic FibrosisLung TransplantationExercise TestHumansPrognosisRetrospective StudiesCFlung transplantationpeak oxygen uptakepeak work ratesurvival.
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.